Abstract:Psoriasis is a chronic inflammatory condition affecting 2% of the Western population. It includes diverse manifestations influenced by genetic predisposition, environmental factors, and immune status. The sustained activation of mTOR is a key element in psoriasis pathogenesis, leading to an uncontrolled proliferation of cytokines. Furthermore, mTOR activation has been linked with the transition from psoriasis to non-skin manifestations such as psoriatic arthritis and cardiovascular events. While therapies targeting pro-inflammatory cytokines have shown efficacy, additional pathways may offer therapeutic potential. The PI3K/Akt/mTOR pathway, known for its role in cell growth, proliferation, and metabolism, has emerged as a potential therapeutic target in psoriasis. This review explores the relevance of mTOR in psoriasis pathophysiology, focusing on its involvement in cutaneous and atheromatous plaque proliferation, psoriatic arthritis, and cardiovascular disease. The activation of mTOR promotes keratinocyte and synovial cell proliferation, contributing to plaque formation and joint inflammation. Moreover, mTOR activation may exacerbate the cardiovascular risk by promoting pro-inflammatory cytokine production and dysregulation lipid and glucose metabolism. The inhibition of mTOR has shown promise in preclinical studies, reducing skin inflammation and plaque proliferation. Furthermore, mTOR inhibition may mitigate cardiovascular risk by modulating cholesterol metabolism and attenuating atherosclerosis progression. Understanding the role of mTOR in psoriasis, psoriatic arthritis, and cardiovascular disease provides insight into the potential treatment avenues and sheds light on the complex interplay of the immune and metabolic pathways in these conditions.

The regulation of skin homeostasis, repair and the pathogenesis of skin diseases by spatiotemporal activation of epidermal mTOR signaling

Roles of Mtor Signaling in Tissue Regeneration

mTOR signaling in hair follicle and hair diseases: recent progress

Senescence in the ageing skin: a new focus on mTORC1 and the lysosome

Epidermal mTORC1 Signaling Contributes to the Pathogenesis of Psoriasis and Could Serve as a Therapeutic Target

Regulation of Hematopoietic Stem Cells Differentiation, Self-Renewal, and Quiescence Through the Mtor Signaling Pathway

The Mtor–s6k Pathway Links Growth Signalling to DNA Damage Response by Targeting RNF168

mTOR Signaling in Growth Control and Disease

Modulation of TSC-mTOR Signaling on Immune Cells in Immunity and Autoimmunity.

Rictor/mTORC2 deficiency enhances keratinocyte stress tolerance via mitohormesis

Pivotal Role of mTOR in Non-Skin Manifestations of Psoriasis

Beyond wavy hairs: the epidermal growth factor receptor and its ligands in skin biology and pathology

Its Critical Role in Metabolic Diseases, Cancer, and the Aging Process

An Updated Review of Mechanotransduction in Skin Disorders: Transcriptional Regulators, Ion Channels, and Micrornas.

Mtor Signaling in Cardiometabolic Disease, Cancer, and Aging

The molecular basis of nutrient sensing and signalling by mTORC1 in metabolism regulation and disease

Role and Therapeutic Targeting of the PI3K/Akt/mTOR Signaling Pathway in Skin Cancer: A Review of Current Status and Future Trends on Natural and Synthetic Agents Therapy

MicroRNA/mRNA regulatory networks in the control of skin development and regeneration

Lipid metabolism, inflammation, and foam cell formation in health and metabolic disorders: targeting mTORC1

The PI3K/Akt Pathway: Emerging Roles in Skin Homeostasis and a Group of Non-Malignant Skin Disorders

The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds